The PGA Tour has released an official statement after announcing a six-month suspension for Trey Mullinax following a violation of the Tour’s Anti-Doping Policy.
The decision comes after Mullinax tested positive for a substance prohibited by the World Anti-Doping Agency (WADA). According to the PGA Tour, the suspension was not related to an attempt to enhance performance, but rather the use of medication for a medical condition without obtaining the required approval under the Tour’s anti-doping rules.
In its statement, the PGA Tour confirmed the disciplinary action and outlined the reason behind the suspension.
“Trey Mullinax has been suspended for six months for violating the PGA Tour Anti-Doping Policy after testing positive for a prohibited substance. The medication was used to treat a condition originally diagnosed in college but was taken without prior approval under the Tour’s Anti-Doping Program.”
The Tour also acknowledged Mullinax’s cooperation throughout the investigation, noting that he worked fully with officials during the review process.
The suspension will keep the 34-year-old out of competition until January 16, 2027, when he becomes eligible to return to the PGA Tour.
Shortly after the announcement, Mullinax accepted responsibility for the violation, admitting that he failed to follow the proper procedures before taking the medication.
“I take full responsibility for what happened,” Mullinax said in his personal statement. “I recently used a medication to treat a condition I was originally diagnosed with in college without seeking approval under the Tour’s Anti-Doping Policy.”
He also emphasized that he never intended to gain a competitive advantage and described the incident as a lesson he will learn from moving forward.
The suspension marks a significant setback for Mullinax, whose lone PGA Tour victory came at the 2022 Barbasol Championship. He will now spend the remainder of the season away from competition before preparing for a return in early 2027.
The PGA Tour reiterated its commitment to maintaining the integrity of professional golf through its anti-doping program, stressing that all members are responsible for ensuring any medication they use complies with the Tour’s regulations, regardless of intent.
With the suspension now confirmed, attention turns to Mullinax’s eventual comeback, as the American looks to rebuild his career when he becomes eligible to compete again next year.